The price per dose of the Russian vaccine against the Sputnik V coronavirus will be much lower than that of the vaccines of the American drug giants Pfizer and Moderna, the official Twitter account of the Russian vaccine said on Sunday.
“Translating the pharmaceutical jargon: The advertised price of Pfizer of $ 19.50 and Moderna of $ 25 to $ 37 per dose actually means their price of $ 39 and $ 50 to $ 74 per person. Two doses are needed per dose. nobody for Pfizer, Sputnik Vaccines V and Moderna. The price of Sputnik V will be much lower, “says the official account.
Translating the pharmaceutical jargon: The advertised price of Pfizer of $ 19.50 and Moderna of $ 25 to $ 37 per dose actually means their price of $ 39 and $ 50 to $ 74 per person. Two doses are needed per person for Pfizer, Sputnik V and Moderna vaccines. The price of the Sputnik V will be much lower. https://t.co/nr1C7RBdZB
– Sputnik V (@sputnikvaccine) November 22, 2020
Russia became the first country to register the world’s first COVID-19 vaccine on August 11. Sputnik V was developed by the Gamaleya National Research Center for Epidemiology and Microbiology of the Russian Ministry of Health.
On November 11, Russia said its Sputnik V vaccine was 92% effective in protecting people from COVID-19 according to the first interim analysis.
On November 17, Moderna, in its official statement, announced that the independent Data Safety Monitoring Board (DSMB), appointed by the NIH in the United States for the Phase 3 study of mRNA-1273, had informed Moderna that the trial met the statistical criteria pre-specified in the study protocol for efficacy, with a vaccine efficacy of 94.5%.
Likewise, on Nov. 18, Pfizer said the final results of the late-stage trial of its coronavirus vaccine were found to be 95% effective and had no serious side effects in the elderly.
(Except for the title, this story was not edited by NDTV staff and is posted from a syndicated feed.)